Tuesday 18 May 2021
British science writer Kevin Davies, Ph.D., is the founding editor of Nature Genetics, the Executive Editor of The CRISPR Journal, and the author of EDITING HUMANITY: The CRISPR Revolution and the New Era of Genome Editing (Pegasus Books, 2020). Kevin’s latest book is the riveting story of the development of the Nobel Prize-winning CRISPR technology for editing genes, driving breakthroughs in science, medicine, and agriculture, while igniting ethical controversies about designer babies and the future of humanity.
Kevin has 30 years’ experience in science publishing and journal editing. He has also served as the chief editor of Cell Press and the publisher of Chemical & Engineering News. His previous books include Breakthrough: The Race for the Breast Cancer Gene; Cracking the Genome (translated into 15 languages), an inside account of the race for the Human Genome Project; and The $1,000 Genome, which details the revolution in personalized medicine and consumer genetics. He also collaborated with Nobel laureate Jim Watson and Andrew Berry on DNA: The Story of the Genetic Revolution. The CRISPR Journal is a sister journal to Human Gene Therapy, which Kevin also supports as Executive Editor.
Kevin holds degrees in biochemistry from Oxford University and a PhD in molecular genetics from the University of London. He did postdoctoral research at MIT and Harvard Medical School before hanging up his lab coat and taking his first editorial position with Nature. He currently resides in Washington DC.